Dengue vaccines: dawning at last? (Q40200462)

18 September 2017

Dengue vaccines: dawning at last? (English)

1 reference

18 September 2017

0 references

Annelies Wilder-Smith

series ordinal

1

object named as

Annelies Wilder-Smith

0 references

language of work or name

English

0 references

publication date

10 July 2014

1 reference

18 September 2017

1 reference

18 September 2017

384

1 reference

18 September 2017

9951

1 reference

18 September 2017

1327-1329

1 reference

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961142-9

7 January 2021

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961142-9

7 January 2021

Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961142-9

7 January 2021

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961142-9

7 January 2021

The structural basis for serotype-specific neutralization of dengue virus by a human antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961142-9

7 January 2021

Identifying protective dengue vaccines: guide to mastering an empirical process

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961142-9

7 January 2021

Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961142-9

7 January 2021

Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961142-9

7 January 2021

Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961142-9

7 January 2021

Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961142-9

7 January 2021

The global distribution and burden of dengue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961142-9

7 January 2021

Dengue: challenges for policy makers and vaccine developers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961142-9

7 January 2021

10.1016/S0140-6736(14)61142-9

Identifiers

DOI

1 reference

18 September 2017

1 reference

PubMed ID

25018119